| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/01/2013 | CN103080079A Phenylcarbamate compound and muscle relaxant containing the same |
| 05/01/2013 | CN103079597A Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same |
| 05/01/2013 | CN103079564A Therapeutic agent for pain |
| 05/01/2013 | CN103079415A Nutritional composition for the stimulation of muscle protein synthesis |
| 05/01/2013 | CN103070946A Chinese patent medicine for treating sclerema neonatorum |
| 05/01/2013 | CN103070832A Cisatracurium besylate lyophilized preparation composition stable at room temperature and preparation method thereof |
| 05/01/2013 | CN102406798B Chinese medicinal composition for treating myasthenia gravis |
| 05/01/2013 | CN102180879B Polycrystalline type alpha acetic acid solvate of hypnotic |
| 05/01/2013 | CN101466389B Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/25/2013 | WO2013059606A1 Compounds and methods for the treatment of muscular disease, and related screening methods |
| 04/25/2013 | WO2013058229A1 Agent for increasing amount of muscles |
| 04/25/2013 | WO2013058194A1 Srf signal activating agent |
| 04/25/2013 | WO2013057231A1 Whey protein micelles to enhance muscle mass and performance |
| 04/25/2013 | WO2013057230A1 Whey protein micelles against muscle atrophy and sarcopenia |
| 04/25/2013 | US20130102898 Liposome including elastin-like polypeptides and use thereof |
| 04/25/2013 | US20130102616 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 04/25/2013 | US20130101580 Compositions and methods for prolonging lifespan |
| 04/25/2013 | CA2853167A1 Whey protein micelles against muscle atrophy and sarcopenia |
| 04/25/2013 | CA2852468A1 Peptidomimetic macrocyles |
| 04/25/2013 | CA2850580A1 Whey protein micelles to enhance muscle mass and performance |
| 04/24/2013 | EP2583970A1 Certain chemical entities, compositions and methods comprising imidazopyrimidines |
| 04/24/2013 | EP2583566A1 Whey protein micelles to enhance muscle mass and performance |
| 04/24/2013 | EP2583563A1 Whey protein micelles against muscle atrophy and sarcopenia |
| 04/24/2013 | CN103068400A Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 04/24/2013 | CN103059020A Rutaecarpin derivative, and preparation method as well as application thereof |
| 04/24/2013 | CN103059017A Design of comprehensive extraction process for barberry plant resources |
| 04/24/2013 | CN103055091A Bone cure pain eliminating paste |
| 04/24/2013 | CN103054939A Preparation technology of liquorice ultrafine powder granular decoction pieces |
| 04/24/2013 | CN103054823A Solid preparation taking distigmine bromide as active ingredient |
| 04/24/2013 | CN102309460B Pyridostigmine bromide odor masking orally disintegrating tablets and preparation method thereof |
| 04/24/2013 | CN101815535B Molecules for targeting compounds to various selected organs or tissues |
| 04/24/2013 | CN101785762B Huperzine A orally disintegrating tablets and preparation method thereof |
| 04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 04/23/2013 | CA2473212C Pharmaceutical composition which improves in vivo gene transfer |
| 04/18/2013 | WO2013055577A1 Selective androgen receptor modulators |
| 04/18/2013 | WO2013055385A2 Methods of treating age related disorders |
| 04/18/2013 | WO2013054866A1 Agent for preventing or treating htlv-i associated myelopathy |
| 04/18/2013 | WO2013053795A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130095190 Oral liquid vitamin and supplement compositions |
| 04/18/2013 | CA2851579A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/18/2013 | CA2851525A1 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
| 04/18/2013 | CA2847889A1 Selective androgen receptor modulators |
| 04/17/2013 | EP2580967A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/17/2013 | CN103045623A Preparation method of tilapia activin receptor IIB recombinant protein and application thereof |
| 04/17/2013 | CN103044477A Trimethyl silicon substituted benzopyran compound and application thereof |
| 04/17/2013 | CN103041228A Traditional Chinese medicine composite for treating myasthenia gravis |
| 04/17/2013 | CN103041175A Novel method for extracting alkaloid from spiranthes sinensis |
| 04/17/2013 | CN103041148A Traditional Chinese medicine formula for treating hiccup singultation |
| 04/17/2013 | CN103041140A Chinese medicinal decoction for treating intractable hiccup |
| 04/17/2013 | CN103041045A Chinese herbal medicine for treating acute lumbar sprain and lumbar muscle strain and preparation method of medicine |
| 04/17/2013 | CN103040980A Traditional Chinese medicine for treating cervical spondylosis |
| 04/17/2013 | CN102309438B Midazolam medicament composition as well as preparation method and application thereof |
| 04/17/2013 | CN102302461B Dantrolene sodium freeze-dried powder injection for injection and preparation method thereof |
| 04/17/2013 | CN101939013B Use of composition for preparing medicine for treating fibromyalgia syndrome and pain from vascular smooth muscle spasm |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420082 Neutralizing antibodies against GDF-8 and uses therefor |
| 04/11/2013 | US20130090465 ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089618 Linseed Salve |
| 04/10/2013 | EP2578228A2 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
| 04/10/2013 | EP2578224A1 Cell growth-promoting peptide and use thereof |
| 04/10/2013 | EP2576619A1 Humanised antigen binding proteins to myostatin6 |
| 04/10/2013 | EP2576618A1 Antibodies to human gdf8 |
| 04/10/2013 | EP2576582A1 Treatment of muscular dystrophy |
| 04/10/2013 | EP2575857A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 04/10/2013 | EP2575831A1 Skeletal muscle regeneration using mesenchymal stem cells |
| 04/10/2013 | EP2575505A1 Dietary formulations |
| 04/10/2013 | CN103037854A Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability |
| 04/10/2013 | CN103033587A Detection method of medicament for treating epilepsia hyperspasmia, infantile convulsions and prosopospasm |
| 04/10/2013 | CN103028005A Preparation method of anti-lumbago tablet and application thereof |
| 04/10/2013 | CN102302565B Stasis eliminating powder for treating soft tissue injury and cervical spondylosis |
| 04/10/2013 | CN101897964B Medicament for preventing autoimmune disease |
| 04/04/2013 | WO2013049293A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013049289A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | WO2013046335A1 Non-aqueous patch |
| 04/04/2013 | WO2013045962A1 Pharmaceutical composition for the prevention and/or treatment of muscle atrophy |
| 04/04/2013 | WO2013045885A1 Treatment for mitrochondrial neurogastrointestinal encephalomyopathy (mngie) |
| 04/04/2013 | WO2013045380A2 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 04/04/2013 | US20130085171 Compounded transdermal pain management |
| 04/04/2013 | US20130085139 Oligomers |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | CA2850100A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/04/2013 | CA2850024A1 Non-aqueous patch |
| 04/04/2013 | CA2849782A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103012254A Pyridone derivatives for modulating stress-activated protein kinase system |
| 04/03/2013 | CN103007024A Traditional Chinese medicine composition for treating prosopospasm |
| 04/03/2013 | CN103006815A Traditional Chinese medicine external use film agent for treating pain diseases caused by rheumatoid bone diseases, cervical muscle and lumbar muscle degeneration, and scapulohumeral periarthritis |
| 04/03/2013 | CN102488713B Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
| 04/03/2013 | CN102048893B Traditional Chinese medicine composition for treating arthromyodynia |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 03/28/2013 | WO2013043580A2 Modified creatine compounds |
| 03/28/2013 | CA2849255A1 A composition and method for treating an autoimmune disease |
| 03/28/2013 | CA2849073A1 Modified creatine compounds |
| 03/27/2013 | EP2573080A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 03/27/2013 | EP2572710A2 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability |